These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38994357)

  • 1. The effect of previous SARS-CoV-2 infection on systemic immune responses in individuals with tuberculosis.
    Xavier MS; Araujo-Pereira M; de Oliveira QM; Sant'Anna FM; Ridolfi FM; de Andrade AMS; Figueiredo MC; Sterling TR; Gordhan BG; Kana BD; Andrade BB; Rolla VC; Gomes-Silva A
    Front Immunol; 2024; 15():1357360. PubMed ID: 38994357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection.
    Najafi-Fard S; Aiello A; Navarra A; Cuzzi G; Vanini V; Migliori GB; Gualano G; Cerva C; Grifoni A; Sette A; Vaia F; Palmieri F; Goletti D
    Int J Infect Dis; 2023 May; 130 Suppl 1():S34-S42. PubMed ID: 36944383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of SARS-CoV-2 seropositivity on antigen - specific cytokine and chemokine responses in latent tuberculosis.
    Rajamanickam A; Pavan Kumar N; Chandrasekaran P; Nancy A; Bhavani PK; Selvaraj N; Karunanithi K; Munisankar S; Srinivasan R; Mariam Renji R; Priya Kumaravadivelu S; Venkatramani V; Babu S
    Cytokine; 2022 Feb; 150():155785. PubMed ID: 34933240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.
    Petrone L; Petruccioli E; Vanini V; Cuzzi G; Najafi Fard S; Alonzi T; Castilletti C; Palmieri F; Gualano G; Vittozzi P; Nicastri E; Lepore L; Antinori A; Vergori A; Caccamo N; Cantini F; Girardi E; Ippolito G; Grifoni A; Goletti D
    Clin Microbiol Infect; 2021 Feb; 27(2):286.e7-286.e13. PubMed ID: 33045370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis.
    Essone PN; Leboueny M; Maloupazoa Siawaya AC; Alame-Emane AK; Aboumegone Biyogo OC; Dapnet Tadatsin PH; Mveang Nzoghe A; Essamazokou DU; Mvoundza Ndjindji O; Padzys GS; Agnandji ST; Takiff H; Gicquel B; Djoba Siawaya JF
    Sci Rep; 2019 Jun; 9(1):8201. PubMed ID: 31160610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic Biomarkers in Peripheral Blood of Persons With Tuberculosis and Advanced HIV.
    Queiroz ATL; Araújo-Pereira M; Barreto-Duarte B; Gomes-Silva A; Costa AG; Andrade AMS; Miguez-Pinto JP; Spener-Gomes R; Souza AB; Benjamin A; Sant'Anna F; Figueiredo MC; Mave V; Salgame P; Ellner JJ; Sterling TR; Cordeiro-Dos-Santos M; Andrade BB; Rolla VC
    Front Immunol; 2022; 13():890003. PubMed ID: 35757685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa.
    Hiemstra AM; MacDonald CE; van Rensburg IC; Stanley K; Maasdorp E; Mc Anda S; Tönsing S; Shaw JA; Tromp G; van der Spuy GD; Urdahl KB; Lewinsohn DM; Kuivaniemi H; Du Plessis N; Malherbe ST; Walzl G
    BMC Infect Dis; 2022 Apr; 22(1):381. PubMed ID: 35428268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterial-specific secretion of cytokines and chemokines in healthcare workers with apparent resistance to infection with
    Shey MS; Balfour A; Masina N; Bekiswa A; Schutz C; Goliath R; Dielle R; Katoto PD; Wilkinson KA; Lewinsohn D; Lewinsohn DA; Meintjes G
    Front Immunol; 2023; 14():1176615. PubMed ID: 37275871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection and pulmonary tuberculosis in children and adolescents: a case-control study.
    Swanepoel J; van der Zalm MM; Preiser W; van Zyl G; Whittaker E; Hesseling AC; Moore DAJ; Seddon JA
    BMC Infect Dis; 2023 Jun; 23(1):442. PubMed ID: 37386354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.
    Vinhaes CL; Oliveira-de-Souza D; Silveira-Mattos PS; Nogueira B; Shi R; Wei W; Yuan X; Zhang G; Cai Y; Barry CE; Via LE; Fukutani KF; Andrade BB; Mayer-Barber KD
    Cytokine; 2019 Nov; 123():154759. PubMed ID: 31226436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.
    Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study.
    MacLean EL; Villa-Castillo L; Espinoza-Lopez P; Caceres T; Sulis G; Kohli M; Pai M; Ugarte-Gil C
    Lancet Microbe; 2023 Jun; 4(6):e452-e460. PubMed ID: 37068500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
    PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective interplay:
    Williams BD; Ferede D; Abdelaal HFM; Berube BJ; Podell BK; Larsen SE; Baldwin SL; Coler RN
    Front Immunol; 2024; 15():1424374. PubMed ID: 38966641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis.
    Pandiarajan AN; Kumar NP; Selvaraj N; Ahamed SF; Viswanathan V; Thiruvengadam K; Hissar S; Shanmugam S; Bethunaickan R; Nott S; Kornfeld H; Babu S
    Front Immunol; 2024; 15():1392256. PubMed ID: 38887283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.